Percutaneous coronary intervention (PCI) remains a cornerstone of treatment for patients with coronary artery disease, yet optimal procedural decision-making is challenged by limitations in traditional angiographic assessment. Emerging technologies such as fractional flow reserve (FFR) and optical coherence tomography (OCT) offer complementary solutions to these challenges. The FUSION study demonstrates that while angiography and OCT tend to overestimate the need for revascularization compared to FFR, OCT-guided stent selection is far superior to angiography alone, reducing discrepancies in device sizing and enhancing procedural safety.
Gary Mintz, MDPanelist
Critique the limitations of angiography and justify the use of physiological indices in PCI decision-making.
Apply OCT findings to select appropriate stent diameter and length during PCI planning.
Design a procedural workflow that integrates FFR and OCT for efficient PCI decision-making.
Assess the clinical benefits and limitations of combining FFR and OCT in routine PCI practice.
Accreditation StatementThe Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit DesignationSCAI designates this journal-based CME activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 0.5 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful CompletionWatch the video and complete the evaliation to obtain credit. Activity TimelineRecording date: 12/16/2025Publish date: 2/4/2026Expiration date: 2/4/2029